Depression is a frequent and debilitating comorbidity that affects heart failure (HF) patients.
Up to 30% of HF patients suffer from depression and even more have depressive symptoms …

Background Phase contrast (PC) cine‐magnetic resonance imaging (MRI) of the coronary
sinus allows for noninvasive evaluation of coronary flow reserve (CFR), which is an index of …

Background Heart failure (HF) readmission rates are low in some jurisdictions. However,
international comparisons are lacking and could serve as a foundation for identifying …

Background: Despite the specific characteristics of heart failure with preserved ejection
fraction (HFpEF) having been demonstrated predominantly from registries in Western …

Background Heart failure (HF) is a major public health problem and represents the only
cardiac disease continuing to increase in prevalence, in particular among elderly patients …

Background Coronary microvascular dysfunction (CMD) has been proposed as a novel
mechanism for the pathophysiology of heart failure (HF) with preserved ejection fraction …

Aims Health services worldwide face the challenge of providing care for increasingly
culturally and linguistically diverse (CALD) populations. The aims of this study were to …

The importance of the central nervous system in cardiovascular events has been
recognized. Recently, brain-derived neurotrophic factor (BDNF), a member of the …

Abstract Thrombospondin-2 (TSP-2) is highly expressed in hypertensive heart. Interstitial
fibrosis is frequently observed in hypertensive heart, and it is a characteristic feature of heart …

Tolvaptan is an oral antagonist of arginine vasopressin receptor 2 that has been approved in
Japan to reduce congestive symptoms in patients with heart failure refractory to loop …